Health
Second study testing a COVID-19 antibody drug has a setback – Mint
The study can continue to test the antibody drug combo in hospitalized patients who need little or no extra oxygen.Lilly and Regeneron have asked the FDA to allow…
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalized patients.Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need intense oxygen treatment or breathing machines — because of a potential safety problem and unfavorable balance of risks and benefits.
The study can continue to test the two-antibody…
-
Noosa News19 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
Noosa News21 hours agoFuel tanker racing to unload in Darwin ahead of Tropical Cyclone Fina
-
Noosa News20 hours agoShattered families demand justice after Wieambilla killers not deemed terrorists
-
General20 hours agoWaste from Perth set to be trucked out to York after WA minister approves landfill site